These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29534065)

  • 41. Investigating the pretreatment miRNA expression patterns of advanced hepatocellular carcinoma patients in association with response to TACE treatment.
    El-Halawany MS; Ismail HM; Zeeneldin AA; Elfiky A; Tantawy M; Kobaisi MH; Hamed I; Abdel Wahab AH
    Biomed Res Int; 2015; 2015():649750. PubMed ID: 25811030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
    Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
    Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma.
    Oura K; Fujita K; Morishita A; Iwama H; Nakahara M; Tadokoro T; Sakamoto T; Nomura T; Yoneyama H; Mimura S; Tani J; Kobara H; Okano K; Suzuki Y; Masaki T
    Oncol Lett; 2019 Jul; 18(1):882-890. PubMed ID: 31289566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
    Sun X; Liu Y; Li M; Wang M; Wang Y
    Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA expression profiles of circulating microvesicles in hepatocellular carcinoma.
    Sun L; Hu J; Xiong W; Chen X; Li H; Jie S
    Acta Gastroenterol Belg; 2013 Dec; 76(4):386-92. PubMed ID: 24592541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway.
    Zhang Z; Yin J; Yang J; Shen W; Zhang C; Mou W; Luo J; Yan H; Sun P; Luo Y; Tian Y; Xiang R
    Oncotarget; 2016 Nov; 7(46):75038-75051. PubMed ID: 27738331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.
    Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
    Front Med; 2015 Sep; 9(3):331-43. PubMed ID: 26293610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.
    Zhang CJ; Du HJ
    Neoplasma; 2017; 64(6):816-823. PubMed ID: 28895405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.
    Assal RA; El Tayebi HM; Hosny KA; Esmat G; Abdelaziz AI
    Mol Med Rep; 2015 Jul; 12(1):645-50. PubMed ID: 25739014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).
    Shi X; Teng F
    Mol Cell Biochem; 2015 Oct; 408(1-2):283-93. PubMed ID: 26160280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.
    Wang Y; Sun B; Sun H; Zhao X; Wang X; Zhao N; Zhang Y; Li Y; Gu Q; Liu F; Shao B; An J
    Tumour Biol; 2016 Aug; 37(8):10965-79. PubMed ID: 26891666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
    Coppola N; de Stefano G; Panella M; Onorato L; Iodice V; Minichini C; Mosca N; Desiato L; Farella N; Starace M; Liorre G; Potenza N; Sagnelli E; Russo A
    Oncotarget; 2017 Apr; 8(15):25289-25299. PubMed ID: 28445974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [MicroRNA profiling in patients with hepatocellular carcinoma].
    Wang CX; Song W; Li ZJ; Song B; Wu DH; Sun AM; Chen LH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):976-7. PubMed ID: 20501372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum miRNA Panel in Egyptian Patients with Chronic Hepatitis C Related Hepatocellular Carcinoma.
    Khairy A; Hamza I; Shaker O; Yosry A
    Asian Pac J Cancer Prev; 2016; 17(5):2699-703. PubMed ID: 27268654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
    Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury.
    Singh AK; Rooge SB; Varshney A; Vasudevan M; Bhardwaj A; Venugopal SK; Trehanpati N; Kumar M; Geffers R; Kumar V; Sarin SK
    Hepatology; 2018 May; 67(5):1695-1709. PubMed ID: 29194684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
    Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
    BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.